Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors

Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors

Recently, modulation of immune checkpoints has risen to prominence as a means to treat a number of solid malignancies, given the durable response seen in many patients and improved side effect profile compared to conventional chemotherapeutic agents. Several classes of immune checkpoint modulators h...

Full description

Bibliographic Details
Main Authors: Nicholas Gravbrot, Kacy Gilbert-Gard, Paras Mehta, Yarah Ghotmi, Madhulika Banerjee, Christopher Mazis, Srinath Sundararajan
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Antibodies
Subjects:
immunotherapy
checkpoint inhibitor
monoclonal antibody
cancer therapy
Online Access:https://www.mdpi.com/2073-4468/8/4/51

Similar Items

Similar Items